Literature DB >> 7858843

Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.

U Windscheif1, V Ralevic, H G Bäumert, E Mutschler, G Lambrecht, G Burnstock.   

Abstract

1. The effect of pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) on vasoconstrictor and/or vasodilator responses to various agonists and electrical field stimulation was investigated in the rat mesenteric arterial bed at basal tone and at tone raised by methoxamine (15-50 microM). 2. At basal tone, nucleotides produced vasoconstriction with the following rank order of potency: alpha,beta-methylene ATP >> 2-methylthio ATP > or = ATP = UTP. PPADS (0.3-10 microM) concentration-dependently antagonized alpha, beta-methylene ATP-, 2-methylthio ATP- and ATP-induced responses. UTP-, noradrenaline- and nerve-mediated (4-32 Hz) increases in perfusion pressure remained unaffected by 10 microM PPADS. 3. In raised tone preparations, nucleotides produced vasodilations, their rank order of potency being 2-methylthio ATP > ATP > UTP. Responses to 2-methylthio ATP were slightly antagonized, whereas ATP- and UTP-induced responses remained unaffected by 10 microM PPADS. In addition, acetylcholine- and adenosine-elicited relaxations were not influenced by 10 microM PPADS. 4. The present results confirm the previously described selective P2x antagonism by PPADS, this compound being ineffective at muscarinic M3- and adenosine P1-receptors as well as at alpha 1-adrenoceptors. There was some inhibition of P2y-purinoceptors but at a much higher concentration than required for inhibition of P2x-purinoceptors. 5. In addition, this study provides evidence for the ineffectiveness of PPADS at both vasoconstriction- and vasodilatation-mediating P2u-purinoceptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858843      PMCID: PMC1510409          DOI: 10.1111/j.1476-5381.1994.tb17094.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats.

Authors:  E K Jackson
Journal:  Am J Physiol       Date:  1987-10

2.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

Review 3.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

4.  A study on the postjunctional excitatory alpha-adrenoreceptor subtypes in the mesenteric arterial bed of the rat.

Authors:  E Pipili
Journal:  J Auton Pharmacol       Date:  1986-06

5.  Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.

Authors:  A U Ziganshin; C H Hoyle; G Lambrecht; E Mutschler; H G Bümert; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

6.  Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.

Authors:  I von Kügelgen; D Häussinger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

7.  P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor.

Authors:  G Burnstock; J J Warland
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

8.  Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery.

Authors:  D Ramme; J T Regenold; K Starke; R Busse; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

9.  Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat.

Authors:  V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

10.  Purinergic receptors: photoaffinity analog of adenosine triphosphate is a specific adenosine triphosphate antagonist.

Authors:  G K Hogaboom; J P O'Donnell; J S Fedan
Journal:  Science       Date:  1980-06-13       Impact factor: 47.728

View more
  22 in total

1.  Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  New insights on P2X purinoceptors.

Authors:  P P Humphrey; G Buell; I Kennedy; B S Khakh; A D Michel; A Surprenant; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  Modelling the P2Y purinoceptor using rhodopsin as template.

Authors:  A M Van Rhee; B Fischer; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1995-11

4.  Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed.

Authors:  V Ralevic; J Jankowski; H Schlüter
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

5.  P2-purinoceptor antagonists: I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates.

Authors:  R Bültmann; B Pause; H Wittenburg; G Kurz; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

6.  PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.

Authors:  S J Charlton; C A Brown; G A Weisman; J T Turner; L Erb; M R Boarder
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

7.  The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.

Authors:  C H Hoyle; A U Ziganshin; J Pintor; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Actions of a Series of PPADS Analogs at P2X1 and P2X3 Receptors.

Authors:  Sean G Brown; Yong-Chul Kim; Soon-Ai Kim; Kenneth A Jacobson; Geoffrey Burnstock; Brian F King
Journal:  Drug Dev Res       Date:  2001-10-18       Impact factor: 4.360

9.  Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.

Authors:  A Rubino; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vessels.

Authors:  I von Kügelgen; B Krumme; U Schaible; P J Schollmeyer; L C Rump
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.